PT2575837E - Estirpes probióticas para usar no melhoramento do sistema nervoso entérico - Google Patents
Estirpes probióticas para usar no melhoramento do sistema nervoso entérico Download PDFInfo
- Publication number
- PT2575837E PT2575837E PT117315044T PT11731504T PT2575837E PT 2575837 E PT2575837 E PT 2575837E PT 117315044 T PT117315044 T PT 117315044T PT 11731504 T PT11731504 T PT 11731504T PT 2575837 E PT2575837 E PT 2575837E
- Authority
- PT
- Portugal
- Prior art keywords
- improving
- nervous system
- probiotic strains
- enteric nervous
- enteric
- Prior art date
Links
- 210000000105 enteric nervous system Anatomy 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2010/001534 WO2011148219A1 (en) | 2010-05-28 | 2010-05-28 | Probiotic strains for use in improving the enteric nervous system |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2575837E true PT2575837E (pt) | 2014-10-01 |
Family
ID=43302705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT117315044T PT2575837E (pt) | 2010-05-28 | 2011-05-27 | Estirpes probióticas para usar no melhoramento do sistema nervoso entérico |
Country Status (14)
Country | Link |
---|---|
US (2) | US9198940B2 (pt) |
EP (2) | EP2575837B1 (pt) |
JP (1) | JP5923492B2 (pt) |
KR (1) | KR101779832B1 (pt) |
CN (1) | CN103209698B (pt) |
BR (1) | BR112012030359B1 (pt) |
CA (1) | CA2800768C (pt) |
EA (1) | EA028015B1 (pt) |
ES (2) | ES2508566T3 (pt) |
MX (1) | MX345063B (pt) |
PL (1) | PL2575837T3 (pt) |
PT (1) | PT2575837E (pt) |
WO (2) | WO2011148219A1 (pt) |
ZA (1) | ZA201208977B (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2609813A1 (en) * | 2011-12-30 | 2013-07-03 | Nestec S.A. | Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system |
UA118339C2 (uk) * | 2012-09-03 | 2019-01-10 | Біогайа Аб | Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти) |
JP2016507216A (ja) | 2012-11-12 | 2016-03-10 | コンパニ・ジェルベ・ダノンCompagnie Gervais Danone | 体脂肪の蓄積を低減させるためのラクトバチルスラムノサス株 |
WO2014096901A1 (en) * | 2012-12-18 | 2014-06-26 | Compagnie Gervais Danone | Strain of bifidobacterium animalis ssp. animalis |
FR3004621B1 (fr) | 2013-04-19 | 2015-05-15 | Gervais Danone Sa | Souche de lactobacillus rhamnosus regulatrice du metabolisme lipidique |
CN103898007B (zh) * | 2014-02-21 | 2016-08-17 | 刘洛贤 | 一株有活性的双歧杆菌菌株 |
JP6402016B2 (ja) * | 2014-12-10 | 2018-10-10 | 国立大学法人岐阜大学 | 神経機能改善剤 |
CN107847483A (zh) * | 2015-04-30 | 2018-03-27 | 益生菌股份公司 | 具有特定治疗活性的抗生素与具有相同治疗适应证的具有不可转移抗生素抗性的乳酸杆菌和/或双歧杆菌同时联用的应用 |
US9730969B2 (en) | 2015-11-06 | 2017-08-15 | Mead Johnson Nutrition Company | Nutritional compositions for promoting gut barrier function and ameliorating visceral pain |
WO2019066599A2 (ko) * | 2017-09-29 | 2019-04-04 | 경희대학교 산학협력단 | 신규 유산균 및 이의 용도 |
CN108753670A (zh) * | 2018-05-28 | 2018-11-06 | 西北工业大学 | 多功能复合微生态制剂纳米硒-重组表达血管活性肠肽-乳酸乳球菌及制备方法 |
KR102238519B1 (ko) * | 2018-12-28 | 2021-04-13 | (주)메디톡스 | 외래 단백질을 발현하는 미생물, 및 그의 용도 |
KR102635553B1 (ko) * | 2018-12-28 | 2024-02-13 | 주식회사 리비옴 | 외래 단백질을 발현하는 미생물, 및 그의 용도 |
CN115066187A (zh) * | 2019-12-17 | 2022-09-16 | 麦特珍尼斯公司 | 多菌株益生菌组合物及其用途 |
KR20210129516A (ko) | 2020-04-20 | 2021-10-28 | 주식회사 리비옴 | 혈관 작동성 장 펩티드를 발현하는 미생물, 및 그의 용도 |
KR102527953B1 (ko) * | 2021-03-29 | 2023-05-03 | 주식회사 리비옴 | 외래 단백질을 발현하는 미생물, 및 그의 용도 |
CN113248520A (zh) * | 2021-04-07 | 2021-08-13 | 浙江华显光电科技有限公司 | 一种有机化合物及使用该化合物的有机发光器件 |
WO2024080918A1 (en) * | 2022-10-13 | 2024-04-18 | Baylor College Of Medicine | Secretin inducing bacteria |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07173188A (ja) * | 1993-12-17 | 1995-07-11 | Tsumura & Co | 新規アリソールおよびアリソール類を有効成分とする脳機能改善剤 |
ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
FR2795917B1 (fr) | 1999-07-06 | 2001-08-31 | Gervais Danone Sa | Procede de preparation d'un produit lacte immunostimulant et ses applications |
FR2811333B1 (fr) | 2000-07-04 | 2003-01-10 | Gervais Danone Sa | Microorganismes ayant une action modulatrice de la glycosylation de surface des cellules intestinales et methode de selection desdits microorganismes |
US20030092163A1 (en) | 2001-07-26 | 2003-05-15 | Collins John Kevin | Probiotic bifidobacterium strains |
FR2875406B1 (fr) | 2004-09-21 | 2007-01-05 | Danisco | Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal |
ITMI20042189A1 (it) * | 2004-11-16 | 2005-02-16 | Anidral Srl | Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale |
DK2277524T3 (en) | 2005-09-28 | 2016-02-08 | Nordisk Rebalance As | Treatment of IBS using both probiotic bacteria and fermented cereal as treatment effectors |
US20090311227A1 (en) | 2006-05-12 | 2009-12-17 | Danisco A/S | Composition |
CN101095698B (zh) * | 2006-06-26 | 2010-12-01 | 青岛东海药业有限公司 | 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途 |
WO2008064489A1 (en) | 2006-12-01 | 2008-06-05 | Mcmaster University | Probiotics to inhibit inflammation |
FR2921795B1 (fr) * | 2007-10-03 | 2011-04-29 | Gervais Danone Sa | Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique |
PL2072053T3 (pl) | 2007-12-21 | 2013-02-28 | Gervais Danone Sa | Sposób zmniejszania obwodu brzucha przez podawanie bakterii bifidobacterium |
WO2010008272A1 (en) * | 2008-07-15 | 2010-01-21 | N.V. Nutricia | Treatment of gut motility disorders |
US8685388B2 (en) * | 2009-11-02 | 2014-04-01 | Compagnie Gervais Danone | Method for reducing gastro-intestinal inflammation using Bifidobacterium animalis bacteria or a fermented dairy product comprising such bacteria |
WO2011148220A1 (en) * | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving transepithelial resistance |
-
2010
- 2010-05-28 WO PCT/IB2010/001534 patent/WO2011148219A1/en active Application Filing
-
2011
- 2011-05-27 ES ES11731504.4T patent/ES2508566T3/es active Active
- 2011-05-27 KR KR1020127034391A patent/KR101779832B1/ko active IP Right Grant
- 2011-05-27 ES ES14173452T patent/ES2744274T3/es active Active
- 2011-05-27 JP JP2013511783A patent/JP5923492B2/ja not_active Expired - Fee Related
- 2011-05-27 EA EA201291441A patent/EA028015B1/ru not_active IP Right Cessation
- 2011-05-27 BR BR112012030359A patent/BR112012030359B1/pt active IP Right Grant
- 2011-05-27 US US13/700,485 patent/US9198940B2/en active Active
- 2011-05-27 CN CN201180036975.4A patent/CN103209698B/zh not_active Expired - Fee Related
- 2011-05-27 EP EP11731504.4A patent/EP2575837B1/en active Active
- 2011-05-27 CA CA2800768A patent/CA2800768C/en active Active
- 2011-05-27 PL PL11731504T patent/PL2575837T3/pl unknown
- 2011-05-27 EP EP14173452.5A patent/EP2857027B1/en active Active
- 2011-05-27 WO PCT/IB2011/052344 patent/WO2011148355A1/en active Application Filing
- 2011-05-27 PT PT117315044T patent/PT2575837E/pt unknown
- 2011-05-27 MX MX2012013834A patent/MX345063B/es active IP Right Grant
-
2012
- 2012-11-28 ZA ZA2012/08977A patent/ZA201208977B/en unknown
-
2015
- 2015-10-29 US US14/927,333 patent/US20160045557A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2857027A1 (en) | 2015-04-08 |
BR112012030359B1 (pt) | 2020-05-05 |
JP2013528053A (ja) | 2013-07-08 |
JP5923492B2 (ja) | 2016-05-24 |
MX2012013834A (es) | 2013-04-08 |
CN103209698A (zh) | 2013-07-17 |
EA201291441A1 (ru) | 2013-05-30 |
BR112012030359A2 (pt) | 2016-08-09 |
ES2508566T3 (es) | 2014-10-16 |
CN103209698B (zh) | 2015-09-02 |
WO2011148355A1 (en) | 2011-12-01 |
PL2575837T3 (pl) | 2015-03-31 |
US9198940B2 (en) | 2015-12-01 |
EP2575837A1 (en) | 2013-04-10 |
EP2575837B1 (en) | 2014-06-25 |
US20160045557A1 (en) | 2016-02-18 |
WO2011148219A1 (en) | 2011-12-01 |
ES2744274T3 (es) | 2020-02-24 |
CA2800768C (en) | 2020-07-21 |
MX345063B (es) | 2017-01-16 |
EP2857027B1 (en) | 2019-06-12 |
EA028015B1 (ru) | 2017-09-29 |
CA2800768A1 (en) | 2011-12-01 |
ZA201208977B (en) | 2014-04-30 |
KR101779832B1 (ko) | 2017-09-19 |
KR20140000620A (ko) | 2014-01-03 |
US20130195822A1 (en) | 2013-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201208977B (en) | Probiotic strains for use in improving the enteric nervous system | |
HK1206390A1 (en) | Bioprotection using lactobacillus paracasei strains | |
HK1206391A1 (en) | Bioprotection using lactobacillus rhamnosus strains | |
ZA201301394B (en) | Tractive effort system and method | |
PL2498789T3 (pl) | Probiotyczny szczep bifidobacterium | |
EP2542744A4 (en) | TRANSITIONAL AUTHENTICATION SYSTEM | |
DK2786756T3 (en) | Kombinationsterapi med en topoisomeraseinhibitor | |
GB201005202D0 (en) | Fueling arrangement and method | |
PL2651423T3 (pl) | Szczepy lactococcus lactis do stosowania w poprawie stanu trawienia | |
GB2482239B (en) | Underlay | |
EP2558137A4 (en) | METHODS AND COMBINATION | |
ZA201303265B (en) | Methods for making and using amino-aldehyde resins | |
EP2616081A4 (en) | METHOD FOR MOBILIZING STEM AND / OR PROGENITOR CELLS | |
ZA201208978B (en) | Probiotic strains for use in improving transepithelial resistance | |
GB201004287D0 (en) | Methods and system | |
IL222821A0 (en) | Spnk strains | |
GB201014904D0 (en) | Travel pillow | |
PL392698A1 (pl) | Sposób otrzymywania polieteroli z pierścieniami azacyklicznymi | |
IL223436A (en) | Methods for preparing tetranor - pgdm and tetranor - pgjm | |
TWM433166U (en) | Pillow | |
GB201001750D0 (en) | Composite and process thereof | |
AU4772P (en) | U2 Neotyphodium uncinatum | |
GB201001384D0 (en) | Light-fitting and associated methods | |
GB201005758D0 (en) | Buffet train | |
TWM388902U (en) | Dual-purpose pillow |